Sarcoidosis following COVID infection: A case series
DJF Smith, J Meghji, M Moonim, C Ross… - Respirology Case …, 2023 - Wiley Online Library
Sarcoidosis following COVID infection: A case series - Smith - 2023 - Respirology Case
Reports - Wiley Online Library Skip to Article Content Skip to Article Information Wiley …
Reports - Wiley Online Library Skip to Article Content Skip to Article Information Wiley …
[HTML][HTML] Genomic analysis of severe COVID-19 considering or not asthma comorbidity: GWAS insights from the BQC19 cohort
Background The severity of COVID-19 is influenced by various factors including the
presence of respiratory diseases. Studies have indicated a potential relationship between …
presence of respiratory diseases. Studies have indicated a potential relationship between …
[HTML][HTML] Finding Facts in Postacute Sequelae of COVID-19: Clinical, Radiographic, and Histopathologic Markers of Disease
CI Pickens, BD Singer - American journal of respiratory and critical …, 2023 - atsjournals.org
The burden of COVID-19 often persists beyond acute SARS-CoV-2 infection. Post-acute
sequelae of COVID-19 (PASC), commonly referred to as long COVID, is defined as …
sequelae of COVID-19 (PASC), commonly referred to as long COVID, is defined as …
[HTML][HTML] Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
M Chianese, G Screm, F Salton, P Confalonieri… - Pharmaceuticals, 2024 - mdpi.com
Pirfenidone and Nintedanib are specific drugs used against idiopathic pulmonary fibrosis
(IPF) that showed efficacy in non-IPF fibrosing interstitial lung diseases (ILD). Both drugs …
(IPF) that showed efficacy in non-IPF fibrosing interstitial lung diseases (ILD). Both drugs …
[HTML][HTML] Viral infection, pulmonary fibrosis, and long COVID
H Hatabu, KM Kaye, DC Christiani - American journal of respiratory …, 2023 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected hundreds of
millions of people worldwide, resulting in longterm complications for many. The multiorgan …
millions of people worldwide, resulting in longterm complications for many. The multiorgan …
The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up
S Zhang, LS Boers, J de Brabander… - … of Physiology-Lung …, 2024 - journals.physiology.org
COVID-19-related acute respiratory distress syndrome (ARDS) can lead to long-term
pulmonary fibrotic lesions. Alveolar fibroproliferative response (FPR) is a key factor in the …
pulmonary fibrotic lesions. Alveolar fibroproliferative response (FPR) is a key factor in the …
Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection
We conducted a prospective single-centre cohort study of 104 multi-ethnic severe COVID-19
survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who …
survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who …
Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy
RH Sansores, A Ramírez-Venegas, F Montiel-Lopez… - Respiratory …, 2023 - Elsevier
Introduction One of the major concerns with post-acute sequelae of COVID-19 (PASC) is the
development of pulmonary fibrosis, for which no approved pharmacological treatment exists …
development of pulmonary fibrosis, for which no approved pharmacological treatment exists …
[HTML][HTML] Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
S Liu, M Zhong, H Wu, W Su, Y Wang, P Li - Microorganisms, 2024 - mdpi.com
Coronavirus disease 2019 (COVID-19) caused a severe epidemic due to severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Recent studies have found that patients …
respiratory syndrome coronavirus-2 (SARS-CoV-2). Recent studies have found that patients …
Comparative single-cell analysis reveals IFN-γ as a driver of respiratory sequelae post COVID-19
Post-acute sequelae of SARS-CoV-2 infection (PASC) represents an urgent public health
challenge, with its impact resonating in over 60 million individuals globally. While a growing …
challenge, with its impact resonating in over 60 million individuals globally. While a growing …